Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: Morphological and functional studies
Authors:
- J.W. ConnJCJ.W. Conn
- D.L. HinermanDHD.L. Hinerman
- 1 December 1977
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 26 (12) , 1293-1307
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effects of Spironolactone, Canrenone and Canrenoate-K on Cytochrome P450, and 11β- and 18-Hydroxylation in Bovine and Human Adrenal Cortical Mitochondria11Endocrinology, 1976
- Diagnosis and Nomenclature of the Disorders of the Terminal Portion of the Aldosterone Biosynthetic PathwayThe Journal of Clinical Endocrinology & Metabolism, 1976
- Diurnal Variation of Plasma Aldosterone, Cortisol and Renin Activity in Supine ManThe Journal of Clinical Endocrinology & Metabolism, 1975
- Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in manNaunyn-Schmiedeberg's Archives of Pharmacology, 1974
- Volume factor in low and normal renin essential hypertensionThe American Journal of Cardiology, 1973
- On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitroNaunyn-Schmiedeberg's Archives of Pharmacology, 1973
- Spironolactone (Aldactone) Bodies: Concentric Lamellar Formations in the Adrenal Cortices of Patients Treated with SpironolactoneAmerican Journal of Clinical Pathology, 1970
- Activation of aldosterone secretion in primary aldosteronismJournal of Clinical Investigation, 1969
- Suppression of Plasma Renin Activity in Primary AldosteronismJAMA, 1964
- CYTOPLASMIC BODIES IN THE ADRENAL CORTEX OF PATIENTS TREATED WITH SPIROLACTONEThe Lancet, 1963